[1]
|
Postow, M.A., Sidlow, R. and Hellmann, M.D. (2018) Immune-Related Adverse Events Associated with Immune Checkpoint Blockade. The New England Journal of Medicine, 378, 158-168. https://doi.org/10.1056/NEJMra1703481
|
[2]
|
Khoja, L., Day, D., et al. (2017) Tumour- and Class-Specific Pat-terns of Immune-Related Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review. Annals of Oncology, 28, 2377-2385.
https://doi.org/10.1093/annonc/mdx286
|
[3]
|
Wang, D.Y., Salem, J.E., Cohen, J.V., et al. (2018) Fatal Toxic Ef-fects Associated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis. JAMA Oncology, 4, 1721-1728.
https://doi.org/10.1001/jamaoncol.2018.3923
|
[4]
|
Bauché, D., Mauze, S., Kochel, C., et al. (2020) Antitumor Effi-cacy of Combined CTLA4/PD-1 Blockade without Intestinal Inflammation Is Achieved by Elimination of FcγR Interac-tions. Journal for ImmunoTherapy of Cancer, 8, e001584. https://doi.org/10.1136/jitc-2020-001584
|
[5]
|
Han, X., Ding, S., Jiang, H., et al. (2021) Roles of Macrophages in the Development and Treatment of Gut Inflammation. Fron-tiers in Cell and Developmental Biology, 9, Article ID: 625423. https://doi.org/10.3389/fcell.2021.625423
|
[6]
|
Mishima, Y. and Sartor, R.B. (2020) Manipulating Resident Micro-biota to Enhance Regulatory Immune Function to Treat Inflammatory Bowel Diseases. Journal of Gastroenterology, 55, 4-14.
https://doi.org/10.1007/s00535-019-01618-1
|
[7]
|
Omenetti, S. and Pizarro, T.T. (2015) The Treg/Th17 Axis: A Dynamic Balance Regulated by the Gut Microbiome. Frontiers in Immunology, 6, Article No. 639. https://doi.org/10.3389/fimmu.2015.00639
|
[8]
|
Chaudhry, A., Samstein, R.M., Treuting, P., et al. (2011) Interleu-kin-10 Signaling in Regulatory T Cells Is Required for Suppression of Th17 Cell-Mediated Inflammation. Immunity, 34, 566-578.
https://doi.org/10.1016/j.immuni.2011.03.018
|
[9]
|
Sasson, S.C., Zaunders, J.J., Nahar, K., et al. (2020) Muco-sal-Associated Invariant T (MAIT) Cells Are Activated in the Gastrointestinal Tissue of Patients with Combination Ipilimumab and Nivolumab Therapy-Related Colitis in a Pathology Distinct from Ulcerative Colitis. Clinical & Experi-mental Immunology, 202, 335-352.
https://doi.org/10.1111/cei.13502
|
[10]
|
Belkaid, Y. and Hand, T.W. (2014) Role of the Microbiota in Immunity and Inflammation. Cell, 157, 121-141.
https://doi.org/10.1016/j.cell.2014.03.011
|
[11]
|
Abu-Sbeih, H., Herrera, L.N., Tang, T., et al. (2019) Correction to: Impact of Antibiotic Therapy on the Development and Response to Treatment of Immune Checkpoint Inhibitor-Mediated Diarrhea and Colitis. Journal for ImmunoTherapy of Cancer, 7, Article No. 352. https://doi.org/10.1186/s40425-019-0832-5
|
[12]
|
Sun, S., Luo, L., Liang, W., et al. (2020) Bifidobacterium Alters the Gut Microbiota and Modulates the Functional Metabolism of T Regulatory Cells in the Context of Immune Check-point Blockade. Proceedings of the National Academy of Sciences of the United States of America, 117, 27509-27515. https://doi.org/10.1073/pnas.1921223117
|
[13]
|
Wang, T., Zheng, N., Luo, Q., et al. (2019) Probiotics Lactobacillus reuteri Abrogates Immune Checkpoint Blockade-Associated Colitis by Inhibiting Group 3 Innate Lymphoid Cells. Fron-tiers in Immunology, 10, Article No. 1235.
https://doi.org/10.3389/fimmu.2019.01235
|
[14]
|
Wang, F., Yin, Q., Chen, L., et al. (2018) Bifidobacterium Can Mitigate Intestinal Immunopathology in the Context of CTLA-4 Blockade. Proceedings of the National Academy of Sci-ences of the United States of America, 115, 157-161.
https://doi.org/10.1073/pnas.1712901115
|
[15]
|
Jinnohara, T., Kanaya, T., Hase, K., et al. (2017) IL-22BP Dictates Characteristics of Peyer’s Patch Follicle-Associated Epithelium for Antigen Uptake. Journal of Experimental Medicine, 214, 1607-1618.
https://doi.org/10.1084/jem.20160770
|
[16]
|
Park, H.J., Lee, S.W., Van Kaer, L., et al. (2021) CD1d-Dependent iNKT Cells Control DSS-Induced Colitis in a Mouse Model of IFNγ-Mediated Hyperinflammation by Increasing IL22-Secreting ILC3 Cells. International Journal of Molecular Sciences, 22, Article No. 1250. https://doi.org/10.3390/ijms22031250
|
[17]
|
Mortha, A., Chudnovskiy, A., Hashimoto, D., et al. (2014) Microbio-ta-Dependent Crosstalk between Macrophages and ILC3 Promotes Intestinal Homeostasis. Science, 343, Article ID: 1249288. https://doi.org/10.1126/science.1249288
|
[18]
|
Fasanello, M.K., Robillard, K.T., Boland, P.M., et al. (2020) Use of Fecal Microbial Transplantation for Immune Checkpoint Inhibitor Colitis. ACG Case Reports Journal, 7, e00360. https://doi.org/10.14309/crj.0000000000000360
|
[19]
|
Coutzac, C., Adam, J., Soularue, E., et al. (2017) Colon Im-mune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities. Journal of Crohn’s and Colitis, 11, 1238-1246.
https://doi.org/10.1093/ecco-jcc/jjx081
|
[20]
|
Zhou, C.B., Zhou, Y.L. and Fang, J.Y. (2021) Gut Microbiota in Can-cer Immune Response and Immunotherapy. Trends in Cancer, 7, 647-660. https://doi.org/10.1016/j.trecan.2021.01.010
|
[21]
|
Kurki, M., Gilbert, S., Mishina, K., et al. (2021) Digital Mental Health Literacy-Program for the First-Year Medical Students’ Wellbeing: A One Group Quasi-Experimental Study. BMC Medical Education, 21, Article No. 563.
https://doi.org/10.1186/s12909-021-02990-4
|
[22]
|
Ding, S.M., Lu, A.L., Zhang, W., et al. (2018) The Role of Cancer-Associated Fibroblast MRC-5 in Pancreatic Cancer. Journal of Cancer, 9, 614-628. https://doi.org/10.7150/jca.19614
|
[23]
|
Zhang, S., Wang, L., Li, M., et al. (2021) The PD-1/PD-L Pathway in Rheumatic Diseases. Journal of the Formosan Medical Association, 120, 48-59. https://doi.org/10.1016/j.jfma.2020.04.004
|
[24]
|
Prakhar, P., Alvarez-DelValle, J., Keller, H., et al. (2021) The Small Intestine Epithelium Exempts Foxp3+ Tregs from Their IL-2 Requirement for Homeostasis and Effector Function. JCI Insight, 6, e149656.
https://doi.org/10.1172/jci.insight.149656
|
[25]
|
Danylesko, I., Bukauskas, A., Paulson, M., et al. (2019) Anti-α4β7 Integrin Monoclonal Antibody (Vedolizumab) for the Treatment of Steroid-Resistant Severe Intestinal Acute Graft-versus-Host Disease. Bone Marrow Transplantation, 54, 987-993. https://doi.org/10.1038/s41409-018-0364-5
|
[26]
|
Zou, F., Faleck, D., Thomas, A., et al. (2021) Efficacy and Safety of Vedolizumab and Infliximab Treatment for Immune-Mediated Diarrhea and Colitis in Patients with Cancer: A Two-Center Observational Study. Journal for ImmunoTherapy of Cancer, 9, e003277. https://doi.org/10.1136/jitc-2021-003277
|
[27]
|
Uemura, M., Trinh, V.A., Haymaker, C., et al. (2016) Selective In-hibition of Autoimmune Exacerbation while Preserving the Anti-Tumor Clinical Benefit Using IL-6 Blockade in a Patient with Advanced Melanoma and Crohn’s Disease: A Case Report. Journal of Hematology & Oncology, 9, Article No. 81.
https://doi.org/10.1186/s13045-016-0309-7
|
[28]
|
Johnson, D., Patel, A.B., Uemura, M.I., et al. (2019) IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from Immunotherapy. Cancer Immunology Research, 7, 860-865.
https://doi.org/10.1158/2326-6066.CIR-18-0682
|
[29]
|
Eksin, M.A., Erden, A., Güven, S.C., et al. (2022) Secuki-numab in the Treatment of Psoriatic Arthritis or Ankylosing Spondyloarthritis with Multiple Sclerosis: A Case Series with Literature Review. Immunotherapy, 14, 401-408.
https://doi.org/10.2217/imt-2021-0128
|
[30]
|
Shaffer, S.R., Traboulsi, C., Krugliak Cleveland, N., et al. (2021) Combining Cyclosporine with Ustekinumab in Acute Severe Ulcerative Colitis. ACG Case Reports Journal, 8, e00604. https://doi.org/10.14309/crj.0000000000000604
|
[31]
|
Nguyen, T.T., Ramsay, L., Ahanfeshar-Adams, M., et al. (2021) Mutations in the IFNγ-JAK-STAT Pathway Causing Resistance to Immune Checkpoint Inhibitors in Melanoma Increase Sensitivity to Oncolytic Virus Treatment. Clinical Cancer Research, 27, 3432-3442. https://doi.org/10.1158/1078-0432.CCR-20-3365
|
[32]
|
Que, J., Van Oerle, R., Albersheim, S., et al. (2021) The Effect of Daily Probiotics on the Incidence and Severity of Necrotizing Enterocolitis in Infants with Very Low Birth Weight. Canadian Journal of Surgery, 64, E644-E649.
https://doi.org/10.1503/cjs.016920
|
[33]
|
Routy, B., Le Chatelier, E., Derosa, L., et al. (2018) Gut Microbiome In-fluences Efficacy of PD-1-Based Immunotherapy against Epithelial Tumors. Science, 359, 91-97. https://doi.org/10.1126/science.aan3706
|